These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 14583983)

  • 1. Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis.
    Taramarcaz P; Gibson PG
    Cochrane Database Syst Rev; 2003; 2003(4):CD003570. PubMed ID: 14583983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of intranasal corticosteroids in combined allergic rhinitis and asthma syndrome.
    Taramarcaz P; Gibson PG
    Clin Exp Allergy; 2004 Dec; 34(12):1883-9. PubMed ID: 15663563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis.
    Lohia S; Schlosser RJ; Soler ZM
    Allergy; 2013; 68(5):569-79. PubMed ID: 23590215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exhaled nitric oxide levels to guide treatment for children with asthma.
    Petsky HL; Kew KM; Chang AB
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011439. PubMed ID: 27825189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
    Chauhan BF; Chartrand C; Ducharme FM
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009611. PubMed ID: 23235678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma.
    Parameswaran K; Belda J; Rowe BH
    Cochrane Database Syst Rev; 2000; (4):CD002742. PubMed ID: 11034753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
    Chauhan BF; Chartrand C; Ducharme FM
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009611. PubMed ID: 23450606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma.
    Edmonds ML; Camargo CA; Pollack CV; Rowe BH
    Cochrane Database Syst Rev; 2003; (3):CD002308. PubMed ID: 12917930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of H1 antihistamine addition to intranasal corticosteroid for allergic rhinitis: a systematic review and meta-analysis.
    Seresirikachorn K; Chitsuthipakorn W; Kanjanawasee D; Khattiyawittayakun L; Snidvongs K
    Int Forum Allergy Rhinol; 2018 Oct; 8(10):1083-1092. PubMed ID: 29917324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal antihistamine is superior to oral H
    Du K; Qing H; Zheng M; Wang X; Zhang L
    Ann Allergy Asthma Immunol; 2020 Nov; 125(5):589-596.e3. PubMed ID: 32650045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of intranasal corticosteroids for the ocular symptoms of allergic rhinitis: A systematic review.
    Hong J; Bielory B; Rosenberg JL; Bielory L
    Allergy Asthma Proc; 2011; 32(1):22-35. PubMed ID: 21262095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma.
    Anderson DE; Kew KM; Boyter AC
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011397. PubMed ID: 26301488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
    Petsky HL; Li A; Chang AB
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD005603. PubMed ID: 28837221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroids for preventing relapse following acute exacerbations of asthma.
    Rowe BH; Spooner CH; Ducharme FM; Bretzlaff JA; Bota GW
    Cochrane Database Syst Rev; 2001; (1):CD000195. PubMed ID: 11279682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal corticosteroids for nasal airway obstruction in children with moderate to severe adenoidal hypertrophy.
    Zhang L; Mendoza-Sassi RA; César JA; Chadha NK
    Cochrane Database Syst Rev; 2008 Jul; 2008(3):CD006286. PubMed ID: 18646145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stepping down the dose of inhaled corticosteroids for adults with asthma.
    Crossingham I; Evans DJ; Halcovitch NR; Marsden PA
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD011802. PubMed ID: 28146601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults.
    Petsky HL; Cates CJ; Li A; Kynaston JA; Turner C; Chang AB
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006340. PubMed ID: 19821360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM; Greenstone IR; Ducharme FM
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate as a steroid sparing agent for asthma in adults.
    Davies H; Olson L; Gibson P
    Cochrane Database Syst Rev; 2000; 1998(2):CD000391. PubMed ID: 10796540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma.
    Edmonds ML; Camargo CA; Pollack CV; Rowe BH
    Cochrane Database Syst Rev; 2001; (1):CD002308. PubMed ID: 11279763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.